title: Mitochondrial-targeted antioxidants protect skeletal muscle against immobilization-induced muscle atrophy.
abstract: Prolonged periods of muscular inactivity (e.g., limb immobilization) result in skeletal muscle atrophy. Although it is established that reactive oxygen species (ROS) play a role in inactivity-induced skeletal muscle atrophy, the cellular pathway(s) responsible for inactivity-induced ROS production remain(s) unclear. To investigate this important issue, we tested the hypothesis that elevated mitochondrial ROS production contributes to immobilization-induced increases in oxidative stress, protease activation, and myofiber atrophy in skeletal muscle. Cause-and-effect was determined by administration of a novel mitochondrial-targeted antioxidant (SS-31) to prevent immobilization-induced mitochondrial ROS production in skeletal muscle fibers. Compared with ambulatory controls, 14 days of muscle immobilization resulted in significant muscle atrophy, along with increased mitochondrial ROS production, muscle oxidative damage, and protease activation. Importantly, treatment with a mitochondrial-targeted antioxidant attenuated the inactivity-induced increase in mitochondrial ROS production and prevented oxidative stress, protease activation, and myofiber atrophy. These results support the hypothesis that redox disturbances contribute to immobilization-induced skeletal muscle atrophy and that mitochondria are an important source of ROS production in muscle fibers during prolonged periods of inactivity.
authors.affiliation: Dept. of Applied Physiology and Kinesiology, Univ. of Florida, Gainesville, FL 32611, USA.
authors.forename: Kisuk
authors.initials: K
authors.lastname: Min
authors.forename: Ashley J
authors.initials: AJ
authors.lastname: Smuder
authors.forename: Oh-Sung
authors.initials: OS
authors.lastname: Kwon
authors.forename: Andreas N
authors.initials: AN
authors.lastname: Kavazis
authors.forename: Hazel H
authors.initials: HH
authors.lastname: Szeto
authors.forename: Scott K
authors.initials: SK
authors.lastname: Powers
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000378:metabolism* / Q000494:pharmacology; D006614:Hindlimb; D007103:Immobilization / Q000009:adverse effects* / Q000379:methods; D008054:Lipid Peroxides / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008931:Mitochondria, Muscle / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D018485:Muscle Fibers, Skeletal / Q000378:metabolism* / Q000502:physiology; D009133:Muscular Atrophy / Q000209:etiology / Q000378:metabolism*; D009210:Myofibrils / Q000378:metabolism; D010084:Oxidation-Reduction; D018384:Oxidative Stress / Q000187:drug effects / Q000502:physiology; D010766:Phosphorylation / Q000502:physiology; D059748:Proteolysis; D011897:Random Allocation; D017382:Reactive Oxygen Species / Q000378:metabolism
chemical_list: D000975:Antioxidants; D008054:Lipid Peroxides; D017382:Reactive Oxygen Species